OMX Copenhagen 25 GI (OMXC25GI.CO)

Close: 1 898.03 (+5.10), Apr 25, 2025
Weak Negative

Low risk

Automatic technical analysis. Short term, Apr 25, 2025

OMX Copenhagen 25 GI shows weak development in a falling trend channel in the short term. Falling trends indicate that the market experiences negative development and falling buy interest among investors. The index has support at points 1710 and resistance at points 2035. The index is assessed as technically slightly negative for the short term.

Recommendation one to six weeks: Weak Negative (Score: -39)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.75%0.00+0.27%
5 days0.002.51%0.00+0.59%
22 days0.006.11%0.00-8.37%
66 days0.0010.93%0.00-6.47%

More analyses of OMX Copenhagen 25 GI

chart OMX Copenhagen 25 GI (OMXC25GI) Candlesticks 22 Days
Candlesticks
chart OMX Copenhagen 25 GI (OMXC25GI) Short term
Short term: Weak Negative
chart OMX Copenhagen 25 GI (OMXC25GI) Medium term
Medium term: Negative
chart OMX Copenhagen 25 GI (OMXC25GI) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.